A 72-year-old woman with type 2 diabetes, hypertension, and CKD stage 3b (eGFR 40 ml/min/1.73m²) is found to have atrial fibrillation on a routine ECG...

Question

A 72-year-old woman with type 2 diabetes, hypertension, and CKD stage 3b (eGFR 40 ml/min/1.73m²) is found to have atrial fibrillation on a routine ECG. Her CHA2DS2-VASc score is 5. According to NICE NG196 and BNF guidance, which DOAC requires dose reduction based solely on her renal function?

Accepted Answer

Edoxaban

Answer

Apixaban

Answer

Rivaroxaban

Answer

Dabigatran

Answer

No DOAC requires dose reduction at this eGFR

mrcgp akt MCQ (SBA): Atrial Fibrillation / Prescribing Safety

A 72-year-old woman with type 2 diabetes, hypertension, and CKD stage 3b (eGFR 40 ml/min/1.73m²) is found to have atrial fibrillation on a routine ECG. Her CHA2DS2-VASc score is 5. According to NICE NG196 and BNF guidance, which DOAC requires dose reduction based solely on her renal function?